No Data
No Data
Yuheng Pharmaceutical (002437.SZ): Net profit of 52.2829 million yuan in the first quarter increased 160.65% year-on-year
Gelonghui, April 26 | Yuheng Pharmaceutical (002437.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 593 million yuan, down 12.92% year on year; net profit attributable to shareholders of listed companies was 52.2829 million yuan, up 160.65% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 32.1407 million yuan, up 136.51% year on year; basic earnings per share were 0.0235 yuan.
Yuheng Pharmaceutical (002437.SZ): 2023 net profit of 120 million yuan, reversing year-on-year losses
Gelonghui, April 19 | Yuheng Pharmaceutical (002437.SZ) released its 2023 annual report. Operating revenue for the reporting period was 2,626 billion yuan, down 15.51% year on year; net profit attributable to shareholders of listed companies was 120 million yuan, turning a year-on-year loss into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 53.3773 million yuan; basic earnings per share were 0.0547 yuan.
Yuheng Pharmaceutical (002437.SZ) Performance Report: 2023 net profit of 120 million yuan reverses year-on-year losses
Gelonghui, April 12 | Yuheng Pharmaceutical (002437.SZ) announced the 2023 annual results report. During the reporting period, the company achieved total operating income of 2,626 billion yuan, a year-on-year decrease of 15.51%; net profit attributable to shareholders of listed companies was 120 million yuan, turning a year-on-year loss into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring profits and losses of 53.3773 million yuan; basic earnings per share were 0.0547 yuan
Express News | Yuheng Pharmaceutical: Net profit for the first quarter of 2024 increased by 149.27%-174.20%
Yuheng Pharmaceutical (002437.SZ) awarded 77.82 million restricted shares to 115 incentive recipients
Yuheng Pharmaceutical (002437.SZ) issued an announcement. The restrictions stipulated in the company's 2024 restricted stock incentive plan...
Yuheng Pharmaceutical (002437.SZ): Shareholder Shen Zhenyu agreed to increase the company's shares by 1%
Gelonghui, Feb. 1, 丨 Yuheng Pharmaceutical (002437.SZ) announced that on February 1, 2024, Harbin Yuheng Pharmaceutical Co., Ltd. received a “Notice Letter” from Shen Zhenyu and its co-actors, Shanghai Fangyuan Dachuang Investment Partnership (Limited Partnership) (“Shanghai Fangyuan”), and learned that between December 14, 2023 and February 1, 2024, Shanghai Fangyuan increased its holdings with “Shanghai Fangyuan Dachuang Investment Partnership (Limited Partnership) - Fangyuan No. 6 Private Equity Fund” (“Fangyuan 6 Fund”) 1 million company shares , accounting for 0 of the company's total share capital.
No Data